Sign in
4

Changes in Ownership

Atea Pharmaceuticals, Inc. Filed Acc 0000899243-21-003868

Options or other derivatives

  • Chief Commercial Officer acquired 117,300 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Vavricka John Chief Commercial Officer 2021-01-29 Grant or award · Stock Option (Right to Buy) +117,300 117,300 D: show line 1 in the form
Loading xslF345X03/doc4.xml…